Warning: The NCBI web site requires JavaScript to function. more...
The inflammatory process of gout and its treatment.
Cronstein BN, Terkeltaub R.
Arthritis Res Ther. 2006;8 Suppl 1:S3. Epub 2006 Apr 12. Review.
Related citations
Management of acute and chronic gouty arthritis: present state-of-the-art.
Schlesinger N.
Drugs. 2004;64(21):2399-416. Review.
Managing problem gout.
Fam AG.
Ann Acad Med Singapore. 1998 Jan;27(1):93-9. Review.
Gout: a review of its aetiology and treatment.
Li EK.
Hong Kong Med J. 2004 Aug;10(4):261-70. Review.
[Therapy of hyperuricemia and gout].
Pöllmann G, Kullich W, Klein G.
Wien Med Wochenschr. 1997;147(16):382-7. Review. German.
Diagnosis and management of acute gout.
Conway N, Schwartz S.
Med Health R I. 2009 Nov;92(11):356-8. Review.
An update on the treatment options for gout and calcium pyrophosphate deposition.
Choy G.
Expert Opin Pharmacother. 2005 Nov;6(14):2443-53. Review.
Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis.
Joosten LA, Netea MG, Mylona E, Koenders MI, Malireddi RK, Oosting M, Stienstra R, van de Veerdonk FL, Stalenhoef AF, Giamarellos-Bourboulis EJ, Kanneganti TD, van der Meer JW.
Arthritis Rheum. 2010 Nov;62(11):3237-48. doi: 10.1002/art.27667.
Updates in the management of gout.
Keith MP, Gilliland WR.
Am J Med. 2007 Mar;120(3):221-4. Review.
Gouty arthritis: understanding the disease state and management options in primary care.
Sunkureddi P.
Adv Ther. 2011 Sep;28(9):748-60. Epub 2011 Aug 31. Review.
Clinical practice. Gout.
Terkeltaub RA.
N Engl J Med. 2003 Oct 23;349(17):1647-55. Review. No abstract available.
A literature review of the epidemiology and treatment of acute gout.
Kim KY, Ralph Schumacher H, Hunsche E, Wertheimer AI, Kong SX.
Clin Ther. 2003 Jun;25(6):1593-617. Review.
[New knowledge on the pathophysiology and therapy of gout].
So A.
Z Rheumatol. 2007 Nov;66(7):562, 564-7. Review. German.
Hyperalgesia, synovitis and multiple biomarkers of inflammation are suppressed by interleukin 1 inhibition in a novel animal model of gouty arthritis.
Torres R, Macdonald L, Croll SD, Reinhardt J, Dore A, Stevens S, Hylton DM, Rudge JS, Liu-Bryan R, Terkeltaub RA, Yancopoulos GD, Murphy AJ.
Ann Rheum Dis. 2009 Oct;68(10):1602-8. Epub 2009 Jun 14.
Advances in the management of gout and hyperuricaemia.
Hoskison TK, Wortmann RL.
Scand J Rheumatol. 2006 Jul-Aug;35(4):251-60. Review.
Assessment and management of gouty arthritis.
Yeomans AC.
Nurse Pract. 1991 Apr;16(4):18, 21, 25-6. Review.
[Pathogenesis, diagnostics and therapy of gout].
Zurek M.
Vnitr Lek. 2006 Jul-Aug;52(7-8):736-41. Review. Czech.
Role of melanocortin receptors in the regulation of gouty inflammation.
Montero-Melendez T, Patel HB, Perretti M.
Curr Rheumatol Rep. 2011 Apr;13(2):138-45. Review.
Treatment of acute gouty arthritis: one physician's approach and where this management stands relative to developments in the field.
Wortmann RL.
Curr Rheumatol Rep. 2004 Jun;6(3):235-9. Review.
Overview of the management of acute gout and the role of adrenocorticotropic hormone.
Drugs. 2008;68(4):407-15. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on